| Early Aggressive Medical Treatment Associated with Selective Prophylactic Aortic Stent-Grafting for Aortic Intramural Hematoma. | |
| | |
MedLine Citation:
|
PMID: 21432754 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Although recent studies suggest that medical treatment is appropriate for patients with aortic intramural hematoma (IMH), the outcomes of supportive medical treatment alone have not been satisfactory, and clear guidelines for medical treatment are not yet available. We assessed whether a management protocol of combined early aggressive medical treatment and selective prophylactic aortic stent-grafting would benefit patients with IMH. METHODS: Nineteen patients with IMH were prospectively studied; after initial clinical and radiological evaluation, 13 underwent early aggressive medical therapy (group 1), and 6 underwent early aggressive medical therapy and prophylactic endovascular stent-grafting (group 2). RESULTS: In group 1, one patient with type A IMH died prior to surgical consultation because of cardiac tamponade; another patient with type A IMH underwent replacement of the ascending aorta at the 6-month follow-up. The condition of the other 11 patients stabilized during hospitalization and after discharge. The disease spontaneously regressed in 10 patients, and the intramural hematoma completely resolved in 5 patients. In group 2, follow-up imaging revealed complete coverage of the penetrating aortic ulcers and regression of the intramural hematoma; endovascular leaks have not yet occurred. CONCLUSIONS: Our protocol may be used as an alternative approach for patients with IMH. After initial clinical and radiological evaluation, the condition of patients without complications can be stabilized with medical treatment; frequent follow-up imaging is required in such cases. Early aggressive medical treatment combined with prophylactic aortic stent-grafting is a safe and effective treatment modality for IMH patients with penetrating aortic ulcers in the descending aorta. |
| | |
Authors:
|
G Zhang; Q Feng; D Zheng; L Ma; R Li; J Jiang; Y Ni |
Related Documents
:
|
21168784 - Expedition medicine--the risk of illness and injury. 21221264 - Long-term sequelae of stroke: how should you handle stroke complications? 21556974 - Optimal medical therapy, lifestyle intervention, and secondary prevention strategies fo... 21199614 - Cost feasibility of a pre-checking medical tourism system for u.s. patients undertaking... 2755534 - Tort claims against health care providers for breach of confidentiality. 9671434 - Evaluation of soluble bioadhesive ophthalmic drug inserts (bodi) for prolonged release ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-22 |
Journal Detail:
|
Title: The Thoracic and cardiovascular surgeon Volume: - ISSN: 1439-1902 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7903387 Medline TA: Thorac Cardiovasc Surg Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Department of Cardiovascular Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Abdominothoracic Fistulas due to Complicated Echinococcosis.
Next Document: Bosentan Effects on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hyper...